 |
Previous Article | Next Article 
Volume 17, Number 13,
Issue of July 1, 1997
pp. 4933-4941
Copyright ©1997 Society for Neuroscience
Chronic Fos-Related Antigens: Stable Variants of FosB Induced
in Brain by Chronic Treatments
Received Feb. 7, 1997; revised April 3, 1997; accepted April 11, 1997.
Jingshan Chen1,
Max B. Kelz1,
Bruce T. Hope2,
Yusaku Nakabeppu3, and
Eric J. Nestler1
1 Laboratory of Molecular Psychiatry, Departments of
Psychiatry and Pharmacology, Yale University School of Medicine,
Connecticut Mental Health Center, New Haven, Connecticut 06508, 2 National Institute of Mental Health, Bethesda, Maryland
20892, and 3 Kyushu University, Fukuoka 812, Japan
Fos family transcription factors are believed to play an important
role in the transcriptional responses of the brain to a variety of
stimuli. Previous studies have described 35 and 37 kDa Fos-like
proteins, termed chronic Fos-related antigens (FRAs), that are induced
in brain in a region-specific manner in response to several chronic
perturbations, including chronic electroconvulsive seizures,
psychotropic drug treatments, and lesions. We show in this study that
the chronic FRAs are isoforms of FosB, a truncated splice variant of
FosB that accumulate in brain after chronic treatments because of their
stability. FosB cDNA encodes the expression of 33, 35, and 37 kDa
proteins that arise from a single AUG translation start site. The 35 and 37 kDa proteins correspond to the chronic FRAs that are induced in
brain by chronic treatments, whereas the 33 kDa protein corresponds to
a Fos-like protein that is induced in brain by acute treatments,
findings based on migration on one- and two-dimensional Western blots
with anti-FRA and anti-FosB antibodies. Using cells in which FosB or
FosB expression is under the control of a tetracycline-regulated gene
expression system, we show that the 37 kDa FosB protein exhibits a
remarkably long half-life, the 35 kDa FosB protein exhibits an
intermediate half-life, and the 33 kDa FosB protein and all
FosB-derived proteins exhibit relatively short half-lives. Moreover, we
show that the 33 kDa FosB protein is the first to appear after
activation of FosB expression. Finally, FosB proteins are shown
to possess DNA-binding activity and to exert potent transactivating
effects in reporter gene assays. Together, these findings support a
scheme wherein FosB, expressed as a 33 kDa protein, is modified to
form highly stable isoforms of 35 and 37 kDa. As a result, these stable
isoforms gradually accumulate in the brain with repeated treatments to mediate forms of long-lasting neural and behavioral plasticity.
Key words:
seizure;
cocaine;
FosB;
chronic Fos-related antigens;
gene expression;
neural plasticity
This article has been cited by other articles:

|
 |

|
 |
 
S. Al-Noori, N. M. Sanders, G. J. Taborsky Jr., C. W. Wilkinson, A. Zavosh, C. West, C. M. Sanders, and D. P. Figlewicz
Recurrent hypoglycemia alters hypothalamic expression of the regulatory proteins FosB and synaptophysin
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2008;
295(5):
R1446 - R1454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. N. Ohnishi, K. Sakumi, K. Yamazaki, Y. H. Ohnishi, T. Miura, Y. Tominaga, and Y. Nakabeppu
Antagonistic Regulation of Cell-Matrix Adhesion by FosB and {Delta}FosB/{Delta}2{Delta}FosB Encoded by Alternatively Spliced Forms of fosB Transcripts
Mol. Biol. Cell,
November 1, 2008;
19(11):
4717 - 4729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J Nestler
Transcriptional mechanisms of addiction: role of {Delta}FosB
Phil Trans R Soc B,
October 12, 2008;
363(1507):
3245 - 3255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Benavides, J. J. Quinn, P. Zhong, A. H. Hawasli, R. J. DiLeone, J. W. Kansy, P. Olausson, Z. Yan, J. R. Taylor, and J. A. Bibb
Cdk5 Modulates Cocaine Reward, Motivation, and Striatal Neuron Excitability
J. Neurosci.,
November 21, 2007;
27(47):
12967 - 12976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Olausson, J. D. Jentsch, N. Tronson, R. L. Neve, E. J. Nestler, and J. R. Taylor
{Delta}FosB in the Nucleus Accumbens Regulates Food-Reinforced Instrumental Behavior and Motivation
J. Neurosci.,
September 6, 2006;
26(36):
9196 - 9204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Ulery, G. Rudenko, and E. J. Nestler
Regulation of {Delta}FosB Stability by Phosphorylation.
J. Neurosci.,
May 10, 2006;
26(19):
5131 - 5142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ron and R. Jurd
The "Ups and Downs" of Signaling Cascades in Addiction
Sci. Signal.,
November 8, 2005;
2005(309):
re14 - re14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Muller and E. M. Unterwald
D1 Dopamine Receptors Modulate {Delta}FosB Induction in Rat Striatum after Intermittent Morphine Administration
J. Pharmacol. Exp. Ther.,
July 1, 2005;
314(1):
148 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Maheux, I. Ethier, C. Rouillard, and D. Levesque
Induction Patterns of Transcription Factors of the Nur Family (Nurr1, Nur77, and Nor-1) by Typical and Atypical Antipsychotics in the Mouse Brain: Implication for Their Mechanism of Action
J. Pharmacol. Exp. Ther.,
April 1, 2005;
313(1):
460 - 473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. I. Perrotti, Y. Hadeishi, P. G. Ulery, M. Barrot, L. Monteggia, R. S. Duman, and E. J. Nestler
Induction of {Delta}FosB in Reward-Related Brain Structures after Chronic Stress
J. Neurosci.,
November 24, 2004;
24(47):
10594 - 10602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nakajima, K. Yamada, T. Nagai, T. Uchiyama, Y. Miyamoto, T. Mamiya, J. He, A. Nitta, M. Mizuno, M. H. Tran, et al.
Role of Tumor Necrosis Factor-{alpha} in Methamphetamine-Induced Drug Dependence and Neurotoxicity
J. Neurosci.,
March 3, 2004;
24(9):
2212 - 2225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Lohmeier, S. Warren, and J. T. Cunningham
Sustained Activation of the Central Baroreceptor Pathway in Obesity Hypertension
Hypertension,
July 1, 2003;
42(1):
96 - 102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Colby, K. Whisler, C. Steffen, E. J. Nestler, and D. W. Self
Striatal Cell Type-Specific Overexpression of Delta FosB Enhances Incentive for Cocaine
J. Neurosci.,
March 15, 2003;
23(6):
2488 - 2493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Ehrlich, J. Sommer, E. Canas, and E. M. Unterwald
Periadolescent Mice Show Enhanced Delta FosB Upregulation in Response to Cocaine and Amphetamine
J. Neurosci.,
November 1, 2002;
22(21):
9155 - 9159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Werme, C. Messer, L. Olson, L. Gilden, P. Thoren, E. J. Nestler, and S. Brene
Delta FosB Regulates Wheel Running
J. Neurosci.,
September 15, 2002;
22(18):
8133 - 8138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Nestler, M. Barrot, and D. W. Self
Delta FosB: A sustained molecular switch for addiction
PNAS,
September 25, 2001;
98(20):
11042 - 11046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, Y. Zhang, M. B. Kelz, C. Steffen, E. S. Ang, L. Zeng, and E. J. Nestler
Induction of Cyclin-Dependent Kinase 5 in the Hippocampus by Chronic Electroconvulsive Seizures: Role of {Delta}FosB
J. Neurosci.,
December 15, 2000;
20(24):
8965 - 8971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Kelz, J. R. Kuszak, Y. Yang, W. Ma, C. Steffen, K. Al-Ghoul, Y.-J. Zhang, J. Chen, E. J. Nestler, and A. Spector
{Delta}FosB-Induced Cataract
Invest. Ophthalmol. Vis. Sci.,
October 1, 2000;
41(11):
3523 - 3538.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. B. Nankova, M. Rivkin, M. Kelz, E. J. Nestler, and E. L. Sabban
Fos-Related Antigen 2: Potential Mediator of the Transcriptional Activation in Rat Adrenal Medulla Evoked by Repeated Immobilization Stress
J. Neurosci.,
August 1, 2000;
20(15):
5647 - 5653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Q. Yuan and H. Yang
Hypothyroidism induces Fos-like immunoreactivity in ventral medullary neurons that synthesize TRH
Am J Physiol Endocrinol Metab,
November 1, 1999;
277(5):
E927 - E936.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hiroi, G. J. Marek, J. R. Brown, H. Ye, F. Saudou, V. A. Vaidya, R. S. Duman, M. E. Greenberg, and E. J. Nestler
Essential Role of the fosB Gene in Molecular, Cellular, and Behavioral Actions of Chronic Electroconvulsive Seizures
J. Neurosci.,
September 1, 1998;
18(17):
6952 - 6962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, M. B. Kelz, G. Zeng, N. Sakai, C. Steffen, P. E. Shockett, M. R. Picciotto, R. S. Duman, and E. J. Nestler
Transgenic Animals with Inducible, Targeted Gene Expression in Brain
Mol. Pharmacol.,
September 1, 1998;
54(3):
495 - 503.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. J. Nestler and G. K. Aghajanian
Molecular and Cellular Basis of Addiction
Science,
October 3, 1997;
278(5335):
58 - 63.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Hiroi, J. R. Brown, C. N. Haile, H. Ye, M. E. Greenberg, and E. J. Nestler
FosB mutant mice: Loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects
PNAS,
September 16, 1997;
94(19):
10397 - 10402.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|